Inclusion Criteria:  aged 60-79 years old living in the community who have a diagnosis of mild-moderate vascular dementia or mixed dementia according to DSM 5 criteria. receiving pharmacological treatment for dementia (cholinesterase inhibitors, memantine), must be on a stable dose for at least 3 months prior to the study. must be able to mobilise independently with or without a mobility aid and without physical assistance. must have a caregiver who either lives with the participant or visits for at least four hours per week.  Exclusion Criteria:  acute and malignant diseases (advanced cancers, end-stage chronic diseases, acute myocardial infarction, stroke) Symptomatic cardiovascular disease, coronary revascularization within 1 year Clinical evidence of schizophrenia, severe depression, psychiatric or bipolar disorder (according to DSM-IV TR criteria) [12] Alcoholism or substance dependence (according to DSM-5 criteria) [13], currently, or within the past 2 years Severe loss of vision, hearing or communicative ability (according to the interRAI Community Health Assessment) [14] Participant or family unwilling to participate in the study